Osteoblast-specific overexpression of human interleukin-7 rescues the bone mass phenotype of interleukin-7-deficient female mice

Journal of Bone and Mineral Research

Volumn 27, Issue 5, 2012, Pages 1030-1042

  Aguila, Hector L ^a   Mun, Se Hwan ^a   Kalinowski, Judith ^a   Adams, Douglas J ^a   Lorenzo, Joseph A ^a   Lee, Sun Kyeong ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

BONE; INTERLEUKIN 7; LYMPHOCYTES; MOUSE MODEL; OSTEOCLASTS

Indexed keywords

INTERLEUKIN 7;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MASS; CYTOKINE PRODUCTION; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYMPHOPOIESIS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLASTOGENESIS; PHENOTYPE; SEX DIFFERENCE;

EID: 84859918677     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1553     Document Type: Article

References (74)

1. Henney C., Interleukin 7: effects on early events in lymphopoiesis. Immunol Today. 1989; 10: 170-3.
2. Namen A, Lupton S, Hjerrild K, Wignall J, Mochizuki DY, Schmierer A, Mosley B, March CJ, Urdal D, Gillis S., Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature. 1988; 333: 571-3.
3. Namen A, Schmierer AE, March CJ, Overell RW, Park LS, Urdal DL, Mochizuki DY., B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J Exp Med. 1988; 167: 988-1002.
4. Andrew D, Aspinall R., Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp Gerontol. 2002; 37: 455-63.
5. Sakata T, Iwagami S, Tsuruta Y, Teraoka H, Tatsumi Y, Kita Y, Nishkawa H, Aiso S, Hibi T, Ishii H., Constitutive expression of interleukin-7 mRNA and production of IL-7 by a cloned murine thymic stromal cell line. J Leukoc Biol. 1990; 48: 205-12.
6. Watanabe M, Ueno Y, Yajima T, Iwao Y, Tsuchiya M, Ishikawa H, Aiso S, Hibi T, Ishii H., Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. J Clin Invest. 1995; 95: 2945-53.
7. Wiles M, Ruiz P, Imhof BA., Interleukin-7 expression during mouse thymus development. Eur J Immunol. 1992; 22: 1037-42.
8. Murray R, Suda T, Wrighton N, Lee F, Zlotnik A., IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets. Int Immunol. 1989; 1: 526-31.
9. Takeda S, Gillis S, Palacios R., In vitro effects of recombinant interleukin 7 on growth and differentiation of bone marrow pro-B and pro-T-lymphocyte clones and fetal thymocyte clone. Proc Natl Acad Sci USA. 1989; 86: 1634-8.
10. Sudo K, Ema H, Morita Y, Nakauchi H., Age-associated characteristics of murine hematopoietic stem cells. J Exp Med. 2000; 192: 1273-80.
11. Goodwin R, Lupton S, Schmierer A, Hjerrild KJ, Jerzy R, Clevenger W, Gillis S, Cosman D, Namen AE., Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci USA. 1989; 86: 302-6.
12. Lee G, Namen AE, Gillis S, Kincade PW., Recombinant interleukin-7 supports the growth of normal B lymphocyte precursors. Curr Top Microbiol Immunol. 1988; 141: 16-8.
13. Conlon P, Morrissey PJ, Nordan RP, Grabstein KH, Prickett KS, Reed SG, Goodwin R, Cosman D, Namen AE., Murine thymocytes proliferate in direct response to interleukin-7. Blood. 1989; 74: 1368-73.
14. Chazen G, Pereira GMB, LeGros G, Gillis S, Shevach EM., Interleukin-7 is a T-cell growth factor. Proc Natl Acad Sci USA. 1989; 86: 5923-7.
15. Morrissey P, Goodwin RG, Nordan RP, Anderson D, Grabstein KH, Cosman D, Sims J, Lupton S, Acres B, Reed SG., Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells. J Exp Med. 1989; 169: 707-16.
16. Park L, Friend DJ, Schmierer AE, Dower SK, Namen AE., Murine interleukin-7 (IL-7) receptor. Characterization on an IL-7-dependent cell line. J Exp Med. 1990; 171: 1073-89.
17. Schlissel M, Durum SD, Muegge K., The interleukin 7 receptor is required for T cell receptor gamma locus accessibility to the V(D)J recombinase. J Exp Med. 2000; 191: 1045-50.
18. Muegge K, Vila MP, Durum SK., Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor beta gene. Science. 1993; 261: 93-5.
19. Lee S, Surh CD., Role of interleukin-7 in bone and T-cell homeostasis. Immunol Rev. 2005; 208: 169-80.
20. Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H, Martin TJ, Suda T., The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology. 1989; 125: 1805-13.
21. 3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells. Endocrinology. 1988; 123: 1504-10.
22. sa-dependent signaling pathways. Proc Natl Acad Sci USA. 2008; 105: 16976-81.
23. Kato I, Sato H, Kudo A., TRANCE together with IL-7 induces pre-B cells to proliferate. Eur J Immunol. 2003; 33: 334-41.
24. Manabe N, Kawaguchi H, Chikuda H, Miyaura C, Inada M, Nagai R, Nabeshima Y-I, Nakamura K, Sinclair AM, Scheuermann RH, Kuro-o M., Connection between B lymphocyte and osteoclast differentiation pathways. J Immunol. 2001; 167: 2625-31.
25. Weitzmann M, Roggia C, Toraldo G, Weitzmann L, Pacifici R., Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J Clin Invest. 2002; 110: 1643-50.
26. Grabstein K, Waldschmidt TJ, Finkelman FD, Hess BW, Alpert AR, Boiani NE, Namen AE, Morrissey PJ., Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody. J Exp Med. 1993; 178: 257-64.
27. Era T, Nishikawa S, Sudo T, Wang FH, Ogawa M, Kunisada T, Hayashi S., How B-precursor cells are driven to cycle. Immunol Rev. 1994; 137: 35-51.
28. Lee S, Kalinowski JF, Jacquin C, Adams DJ, Gronowicz G, Lorenzo JA., Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss. J Bone Miner Res. 2006; 21: 695-702.
29. Miyaura C, Onoe Y, Inada M, Maki K, Ikuta K, Ito M, Suda T., Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc Natl Acad Sci USA. 1997; 94: 9360-5.
30. Weitzmann M, Cenci S, Rifas L, Brown C, Pacifici R., Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. Blood. 2000; 96: 1873-8.
31. Toraldo G, Roggia C, Qian W-P, Pacific R, Weitzmann MN., IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kB ligand and tumor necrosis factor a from T cells. Proc Natl Acad Sci USA. 2002; 100: 125-30.
32. Ryan M, Shepherd R, Leavey JK, Gao Y, Grassi F, Schnell FJ, Qian WP, Kersh GJ, Weitzmann MN, Pacifici R., An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency. Proc Natl Acad Sci USA. 2005; 102: 16735-40.
33. Sudo T, Nishikawa S, Ohno N, Akiyama N, Tamakoshi M, Yoshida H, Nishikawa SI., Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc Natl Acad Sci USA. 1993; 90: 9125-9.
34. Bhatia S, Tygrett LT, Grabstein KH, Waldschmidt TJ., The effect of in vivo IL-7 deprivation on T cell maturation. J Exp Med. 1995; 181: 1399-409.
35. Morrissey P, Conlon P, Charrier K, Braddy S, Alpert A, Williams D, Namen AE, Mochizuki D., Administration of IL-7 to normal mice. J Immunol. 1991; 147: 561-8.
36. Fraser C, Thacker JD, Hogge DE, Fatur-Saunders D, Takei F, Humphries RK., Alterations in lymphopoiesis after hematopoietic reconstitution with IL-7 virus-infected bone marrow. J Immunol. 1993; 151: 2409-18.
37. Mertsching E, Grawunder U, Meyer V, Rolink T, Ceredig R., Phenotypic and functional analysis of B lymphopoiesis in interleukin-7-transgenic mice: expansion of pro/pre-B cell number and persistence of B lymphocyte development in lymph nodes and spleen. Eur J Immunol. 1996; 26: 28-33.
38. Valenzona H, Pointer R, Ceredig R, Osmond DG., Prelymphomatous B cell hyperplasia in the bone marrow of interleukin-7 transgenic mice: precursor B cell dynamics, microenvironmental organization and osteolysis. Exp Hematol. 1996; 24: 1521-9.
39. Mertsching E, Meyer V, Linares J, Lombard-Platet S, Ceredig R., Interleukin-7, a non-redundant potent cytokine whose over-expression massively perturbs B-lymphopoiesis. Int Rev Immunol. 1998; 16: 285-308.
40. Fisher A, Burdet C, Bunce C, Merkenschlager M, Ceredig R., Lymphoproliferative disorders in IL-7 transgenic mice: expansion of immature B cells which retain macrophage potential. Int Immunol. 1995; 7: 415-23.
41. Salopek D, Grčević D, Katavić V, Kovačić N, Lukić IK, MaruÅić A., Increased bone resorption and osteopenia are a part of the lymphoproliferative phenotype of mice with systemic over-expression of interleukin-7 gene driven by MHC class II promoter. Immunol Lett. 2008; 121: 134-9.
42. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SEG, Murray R., Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med. 1995; 181: 1519-26.
43. Maeurer M, Lotze MT., Interleukin-7 (IL-7) knockout mice: implications for lymphopoiesis and organ-specific immunity. Int Rev Immunol. 1998; 16: 309-22.
44. Rich B., Autocrine expression of interleukin-7 rescues lymphoid expansion in interleukin-7 deficient mice. Immunol Today. 1997; 92: 374-80.
45. Maki K, Sunaga S, Komagata Y, Kodaira Y, Mabuchi A, Karasuyama H, Yokomuro K, Miyazaki J, Ikuta K., Interleukin-7 receptor-deficient mice lack gdT cells. Proc Natl Acad Sci USA. 1996; 93: 7172-7.
46. Pechon J, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Zigler SF, Williams DE, Ware CB, Meyer JD, Davidson BL., Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med. 1994; 180: 1955-60.
47. Lee S, Kalinowski JF, Jastrzebski SL, Puddington L, Lorenzo JA., Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis. Endocrinology. 2003; 144: 3524-31.
48. Brunton L, Lupton SD., Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci USA. 1989; 86: 302-6.
49. Chirgwin J, Przybyla AE, MacDonald RJ, Rutter WJ., Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979; 18: 5294-9.
50. Alonso S, Minty A, Bourlet Y, Buckingham M., Comparison of the three actin-coding sequences in the mouse: evolutionary relationships between the actin genes of warm-blooded vertebrates. J Mol Evol. 1986; 23: 11-22.
51. Parfitt A, Drezner MK, Vlorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR., Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987; 2: 595-610.
52. Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyde A, Suda T., Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology. 1988; 122: 1373-82.
53. Lee S-K, Goldring SR, Lorenzo JA., Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin. Endocrinology. 1995; 136: 4572-81.
54. Akatsu T, Tamura T, Takahashi N, Udagawa N, Tanaka S, Sasaki T, Yamaguchi A, Nagata N, Suda T., Preparation and characterization of a mouse osteoclast-like multinucleated cell population. J Bone Miner Res. 1992; 7: 1297-306.
55. Akatsu T, Takahashi N, Debari K, Morita I, Nagata N, Takatani O, Suda T., Prostaglandins promote osteoclast-like cell formation by a mechanism involving cyclic adenosine 3',5'-monophosphate in mouse bone marrow cell cultures. J Bone Miner Res. 1989; 4: 29-35.
56. Shuto T, Kukita T, Hirata M, Jimi E, Koga T., Dexamethasone stimulates osteoclast-like cell formation by inhibiting granulocyte-macrophage colony-stimulating factor production in mouse bone marrow cultures. Endocrinology. 1994; 134: 1121-6.
57. Menaa C, Kurihara N, Roodman GD., CFU-GM-derived cells form osteoclasts at a very high efficiency. Biochem Biophys Res Comm. 2000; 267: 943-6.
58. Kalajzic I, Kalajzic Z, Kaliterna M, Gronowicz G, Clark SH, Lichtler AC, Rowe D., Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res. 2002; 17: 15-25.
59. Vogt T, Link A, Perrin J, Finke D, Luther SA., Novel function for interleukin-7 in dendritic cell development. Blood. 2009; 113: 3961-8.
60. Zhu J, Garrett R, Jung Y, Zhang Y, Kim N, Wang J, Joe GJ, Hexner E, Choi Y, Taichman R, Emerson SG., Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. Blood. 2007; 109: 3706-12.
61. Tokoyoda K, Egawa T, Sugiyama T, Choi B, Nagasawa T., Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity. 2004; 20: 707-18.
62. + T lymphocytes in osteoclast differentiation in vitro. Endocrinology. 1996; 137: 2457-63.
63. Choi Y, Woo KM, Ko SH, Lee YJ, Park SJ, Kim HM, Kwon BS., Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells. Eur J Immunol. 2001; 31: 2197-88.
64. 3- stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis. J Immunol. 2000; 165: 4231-8.
65. Miller J, Allman D., Linking age-related defects in B lymphopoiesis to the aging of hematopoietic stem cells. Semin Immunol. 2005; 17: 321-9.
66. Merchant M, Garvy BA, Riley RL., B220 bone marrow progenitor cells from New Zealand black autoimmune mice exhibit an age-associated decline in pre-B and B-cell generation. Blood. 1995; 85: 1850-7.
67. Stephan R, Reilly CR, Witte PL., Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood. 1998; 91: 75-88.
68. Medina K, Garrett KP, Thompson LF, Rossi MI, Payne KJ, Kincade PW., Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat Immunol. 2001; 8: 718-24.
69. Igarashi H, Kouro T, Yokota T, Comp PC, Kincade PW., Age and stage dependency of estrogen receptor expression by lymphocyte precursors. Proc Natl Acad Sci USA. 2001; 98: 15131-6.
70. Jacome C, Lee SK, Lorenzo J, Aguila KL., Identification and characterization of a common progenitor for osteoclasts, macrophages and dendritic cells in murine bone marrow. J Bone Miner Res. 2010; 25: S302.
71. Horowitz MC, Fretz JA, Lorenzo JA., How B cells influence bone biology in health and disease. Bone. 2010; 47: 472-9.
72. Jacquin C, Gran DE, Lee SK, Lorenzo JA, Aguila HL., Identification of multiple osteoclast precursor populations in murine bone marrow. J Bone Miner Res. 2006; 21: 67-77.
73. Li Y, Toraldo G, Li A, Yang X, Zhang H, Qian WP, Weitzmann MN., B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood. 2007; 109: 3839-48.
74. Horowitz M, Xi Y, Pflugh DL, Hesslein DGT, Schatz DG, Lorenzo JA, Bothwell ALM., Pax5 deficient mice exhibit early onset osteoporosis with increased osteoclast progenitors. J Immunol. 2004; 173: 6583-91.